Skip to main content

Advertisement

SpringerLink
Log in

Aetiology and Pathophysiology of Chronic Liver Disorders

  • Published:
Drugs Aims and scope Submit manuscript

Summary

The aetiology of chronic liver disease covers a wide range of congenital or acquired abnormalities of the hepatocellular biochemical network. Although our knowledge has considerably increased in recent years, the aetiology of chronic liver disease often remains obscure. Acquired irreversible disturbances of normal liver function can be mediated by hepatotrophic viruses, chemicals, chronic oxygen depletion, or interference with the immune system. Considerable progress has been made in the detection and characterisation of hepatitis B, C, and D viruses as causative agents of chronic active hepatitis. Alcohol abuse remains the predominant cause of chronic liver disease in the Western world. The targets of autoantibodies used to diagnose autoimmune diseases of the liver and primary biliary cirrhosis continue to be biochemically defined. Their significance for the aetiology of the disease, however, remains to be established.

Nonparenchymal cells play an important role in the sequence of events following hepatocellular injury and ultimately leading to liver cirrhosis. They release vasoactive compounds, cytokines, and other important mediators, and participate in the modulation of the extracellular matrix that is characteristic of liver fibrosis and cirrhosis. The biochemical basis of liver cell necrosis remains poorly defined. In spite of recent progress, and the detection of some new pathogenic principles that help in the understanding of the complications of chronic liver disease such as portal hypertension, oesophagogastric variceal bleeding, portosystemic encephalopathy, ascites, and other metabolic disturbances, many questions concerning the aetiology and pathophysiology of chronic liver disease and its complications remain to be answered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alagille D, Odievre M, Gautier MJP. Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformation, retarded physical, mental and sexual development and cardiac murmur. Journal of Pediatrics 86: 63–71, 1975

    PubMed  CAS  Google Scholar 

  • Ala-Kokko L, Stenbäck F, Ryhänen L. Preventive effect of malotilate on carbon tetrachloride-induced liver damage and collagen accumulation in the rat. Biochemical Journal 246: 503–509, 1987

    PubMed  CAS  Google Scholar 

  • Avigan MI, Adamson G, Hoofnagle JH, Jones EA. The in vitro production of antibodies to mitochondrial antigens by peripheral blood mononuclear cells from patients with primary biliary cirrhosis. Hepatology 6: 999–1004, 1986

    PubMed  CAS  Google Scholar 

  • Bacon BR, Britton RS. The pathology of hepatic iron overload: a free radical-mediated process? Hepatology 11: 127–137, 1990

    PubMed  CAS  Google Scholar 

  • Barron R, Grace ND, Sherwood G, Powell LW. Iron overload complicating sideroblastic anemia. Is the gene for hemochromatosis responsible? Gastroenterology 96: 1204–1206, 1989

    PubMed  CAS  Google Scholar 

  • Bassen ML, Powell LW. Genetic hemochromatosis. Seminars in Liver Diseases 4: 217–227, 1984

    Google Scholar 

  • Benoit JN, Wocmack WA, Hernandez L, Granger DN. ‘Forward’ and ‘backward’ flow mechanisms of portal hypertension. Gastroenterology 89: 1096–1099, 1985

    Google Scholar 

  • Berthelot P, Dhumeaux D. New insights into the classification and mechanisms of hereditary, chronic, non-haemolytic hyperbilirubinaemias. Gut 19: 474–480, 1978

    PubMed  CAS  Google Scholar 

  • Blei AT. Vasodilator therapy of portal hypertension: focus on the liver. Hepatology 9: 896–899, 1989

    PubMed  CAS  Google Scholar 

  • Blumberg RS, Chopra S, Ibrahim R, Crawford J, Farraye FA, et al. Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis. Gastroenterology 95: 1399–1402, 1988

    PubMed  CAS  Google Scholar 

  • Bodenheimer HC, LaRusso NF, Thayer WR, Charland C, Staples PJ, et al. Elevated circulating immune complex in primary sclerosing cholangitis. Hepatology 3: 150–154, 1983

    PubMed  Google Scholar 

  • Börsch G, Schmidt G. Halothan-assoziierte Leberschäden: Metabolische, immunologische und genetische Mechanismen. Medizinische Klinik 82: 450–455, 1987

    PubMed  Google Scholar 

  • Brinch L, Teisberg P, Schrumpf E, Akesson I. The in vivo metabolism of C3 in hepatobiliary disease associated with ulcerative colitis. Scandinavian Journal of Gastroenterology 17: 523–527, 1982

    PubMed  CAS  Google Scholar 

  • Burroughs AK, Butler P, Brown D, Brumfitt W, Miller JH, et al. Specific reactivity of a mitochondrial antibody in women with recurrent urinary tract infection against the PBC specific 70 kD mitochondrial (M2) autoantigen demonstrated by immunopurification. Journal of Hepatology 9: S130, 1989

    Google Scholar 

  • Burroughs AK, Rosenstein IJ, Epstein O, Hamilton-Miller JMT, Brumfitt W, et al. Bacteriuria and primary biliary cirrhosis. Gut 25: 133–137, 1984

    PubMed  CAS  Google Scholar 

  • Buscher H-P, Wilson Krankheit. In Gerok W (Ed.) Hepatologie, pp. 403–414, Urban & Schwarzenberg, München, 1987

    Google Scholar 

  • Caramelo C, Fernandez-Gallardo S, Santos JC, Inarrea P, Sanchez-Crespo M, et al. Increased levels of platelet-activating factor in blood from patients with cirrhosis of the liver. European Journal of Clinical Investigation 17: 7–11, 1987

    PubMed  CAS  Google Scholar 

  • Carrell RW, Jeppsson J-O, Laureil C-B, Brennan S-O, Owen MC, et al. Structure and variation of human α1-antitrypsin. Nature 298: 329–334, 1982

    PubMed  CAS  Google Scholar 

  • Chapman RW, Cottone M, Selby WS, Shepherd HA, Sherlock S, et al. Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut 27: 86–91, 1986

    PubMed  CAS  Google Scholar 

  • Chapman RW, Kelly PMA, Heryet A, Jewell DP, Fleming KA. Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis. Gut 29: 422–427, 1988

    PubMed  CAS  Google Scholar 

  • Chapman RW, Varghese Z, Gaul R, Kokkinson N, Sherlock S. Association of primary sclerosing cholangitis with HLA-B8. Gut 24: 38–41, 1983

    PubMed  CAS  Google Scholar 

  • Chevillotte G, Dubrec JP, Gerolami A, Berthezene P, Bidart JM, et al. Interaction between hepatitis B virus and alcohol consumption in liver cirrhosis. An epidemiologic study. Gastroenterology 85: 141–145, 1983

    PubMed  CAS  Google Scholar 

  • Chowdhury JR, Wolkoff AW, Arias IM. Heme and bile pigment metabolism. In Arias IM et al. (Eds) The liver: biology and pathobiology, pp. 419–449, Raven Press, New York, 1988

    Google Scholar 

  • Cofrancesco E, Salvatore M, Fenu MP, Pogliani EM. Primary shunt hyperbilirubinemia associated with Gilbert’s syndrome. American Journal of Clinical Pathology 79: 627–629, 1983

    PubMed  CAS  Google Scholar 

  • Coppel RL, McNeilage LJ, Surh CD, Van de Water J, Spithill TW, et al. Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase. Proceedings of the National Academy of Science USA 85: 7317–7321, 1988

    CAS  Google Scholar 

  • Cousins RJ. Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiological Reviews 65: 238–309, 1985

    PubMed  CAS  Google Scholar 

  • Cox DW, Smyth S. Risk for liver disease in adults with α1-antitrypsin deficiency. American Journal of Medicine 74: 221–227, 1983

    PubMed  CAS  Google Scholar 

  • Czaja MJ, Weiner FR, Schwarzenberg SJ, Sternlieb I, Scheinberg IH, et al. Molecular studies of ceruloplasmin deficiency in Wilson’s disease. Journal of Clinical Investigation 80: 1200–1204, 1987

    PubMed  CAS  Google Scholar 

  • Das KM, Jeffers L, Squuillante L, Hyder S, Reddy R, et al. The presence of circulating antibodies in patients with sclerosing cholangitis against an epitope(s) on MR 40,000 protein shared by colon and bile duct epithelial cells. Gastroenterology 96: A590, 1989

    Google Scholar 

  • Davis BH. Hepatic fibrogenesis: new developments? American Journal of Gastroenterology 82: 544–546, 1987

    PubMed  CAS  Google Scholar 

  • de Groot H, Noll T. Halothane hepatotoxicity: relation between metabolic activation, hypoxia, covalent binding, lipid peroxidation and liver cell damage. Hepatology 3: 601–606, 1983

    PubMed  Google Scholar 

  • DiPadova C, Worner TM, Julkunen RJ, Lieber CS. Effects of fasting and chronic alcohol consumption on the first-pass metabolism of ethanol. Gastroenterology 92: 1169–1173, 1987

    PubMed  CAS  Google Scholar 

  • Dölle W. Leberschädigung durch Arzneimittel. Deutsche Zeitschrift für Verdauungs- und Stoffwechselkrankheiten 42: 237–244, 1982

    PubMed  Google Scholar 

  • Doss M. Hepatic porphyrias. Pathobiochemical, diagnostic and therapeutic implications. In Popper H, Schaffner F (Eds) Progress in Liver Diseases, Vol. 7, pp. 573–598, Grune & Stratton, New York, 1982

    Google Scholar 

  • Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, et al. Prevalence of hemochromatosis among 11,066 presumably healthy blood donors. New England Journal of Medicine 318: 1355–1362, 1988

    PubMed  CAS  Google Scholar 

  • Elias E, Mitchell SJ, Bloom BR. Vasoactive intestinal peptide in cirrhosis. Lancet 2: 1312, 1975

    PubMed  CAS  Google Scholar 

  • El-Shabrawi M, Wilkinson ML, Portmann B, Mieli-Vergani G, Chong SKF, et al. Primary sclerosing cholangitis in childhood. Gastroenterology 92: 1226–1235, 1987

    PubMed  CAS  Google Scholar 

  • Endo T, Uchida K, Amuro Y, Higashino K, Yamamura Y. Bile acid metabolism in benign recurrent intrahepatic cholestasis. Gastroenterology 76: 1002–1006, 1979

    PubMed  CAS  Google Scholar 

  • Epstein M. The kidney in liver disease. In Arias IM et al. (Eds) The liver: biology and pathobiology, pp. 1043–1062, Raven Press, New York, 1988

    Google Scholar 

  • Eriksson S, Carson J, Velez R. Risk of cirrhosis and primary liver cancer in α1-antitrypsin deficiency. New England Journal of Medicine 314: 736–739, 1986

    PubMed  CAS  Google Scholar 

  • Eyhorn S, Leuthner DP, Becker H, Henninger H, Decker K. Metabolites of arachidonic acid produced by rat sinusoidal endothelial cells in primary culture. In Kirn A et al. (Eds) Cells of the hepatic sinusoid, pp. 83–94, Kupffer Cell Foundation, Rijswijk, 1986

    Google Scholar 

  • Farrell G, Prendergast D, Murray M. Halothane hepatitis. Detection of a constitutional susceptibility factor. New England Journal of Medicine 313: 1310–1314, 1985

    PubMed  CAS  Google Scholar 

  • Fisher MM. Mechanisms of drug-induced cholestasis. Seminars in Liver Diseases 1: 151–156, 1981

    CAS  Google Scholar 

  • Floreani A, Bassendine MF, Mitchison H, Freeman R, James OFW. No specific association between primary biliary cirrhosis and bacteriuria? Journal of Hepatology 8: 201–207, 1989

    PubMed  CAS  Google Scholar 

  • Freedman JH, Ciriolo MR, Peisach J. The role of glutathione in copper metabolism and toxicity. Journal of Biological Chemistry 264: 5598–5605, 1989

    PubMed  CAS  Google Scholar 

  • French SW, Miyamoto K, Wong K, Jui L, Briere L. Role of the Ito-cell in parenchymal fibrosis in rats fed alcohol and a high fat-low protein diet. American Journal of Pathology 132: 73–85, 1988

    PubMed  CAS  Google Scholar 

  • Frezza M, DiPadova C, Pozzato G Terpin M, Baraona E, et al. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. New England Journal of Medicine 322: 95–99, 1990

    PubMed  CAS  Google Scholar 

  • Friedman SL, Roll FJ, Boyles J, Bissel DM. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proceedings of the National Academy of Sciences of the United States of America 82: 8681–8685, 1988

    Google Scholar 

  • Froesch ER. Disorders of fructose metabolism. Clinics in Endocrinology and Metabolism 5: 599–611, 1976

    PubMed  CAS  Google Scholar 

  • Frostell A, Mendel-Hartvig I, Nelson BD, Tötterman TH, Björkland A, et al. Evidence that the major primary biliary cirrhosis-specific mitochondrial autoantigen is a subunit of complex I of the respiratory chain. Scandinavian Journal of Immunology 28: 157–165, 1988

    PubMed  CAS  Google Scholar 

  • Frydman M, Bonné-Tamir B, Farrer LA, Conneally PM, Magazanik A, et al. Assignment of the gene for Wilson disease to chromosome 13: linkage to the esterase D locus. Proceedings of the National Academy of Science USA 82: 1819–1821, 1985

    CAS  Google Scholar 

  • Garcia-Tsao G, Groszman RJ, Fisher RL, Conn HO, Atterbury CE, et al. Portal pressure, pressure of gastroesophageal varices and variceal bleeding. Hepatology 5: 419–424, 1985

    PubMed  CAS  Google Scholar 

  • Gaskin KJ, Waters DLM, Howman-Giles R, de Silva M, Earl JW, et al. Liver disease and common-bile-duct stenosis in cystic fibrosis. New England Journal of Medicine 318: 340–346, 1988

    PubMed  CAS  Google Scholar 

  • Gentilini P, Laffi G, Meacci E, La Villa G, Cominelli F, et al. Effects of OKY 046, a thromboxane-synthase inhibitor, on renal function in nonazotemic cirrhotic patients with ascites. Gastroenterology 94: 1470–1477, 1988

    PubMed  CAS  Google Scholar 

  • Gitzelmann R, Steinmann B, van den Berghe G. Essential fructosuria, hereditary fructose intolerance, and fructose-1,6-diphosphatase deficiency. In Stanbury JB et al. (Eds) The metabolic basis of inherited disease, 5th ed., pp. 118–140, McGraw-Hill, New York, 1983

    Google Scholar 

  • Gressner AM. Zum gegenwärtigen Stand der Pathobiochemie und klinisch-chemischen Laboratoriumsdiagnostik der Leberfibrose. Medizinische Klinik 82: 700–710, 1987

    PubMed  CAS  Google Scholar 

  • Gross JB, Myers BM, Kost LJ, Kuntz SM, LaRusso NF. Biliary copper excretion by hepatocyte lysosomes in the rat. Major excretory pathway in experimental copper overload. Journal of Clinical Investigation 83: 30–39, 1989

    PubMed  CAS  Google Scholar 

  • Guarner F, Guarner C, Prieto J, Colina I, Quiroga J, et al. Increased synthesis of systemic prostacyclin in cirrhotic patients. Gastroenterology 90: 687–694, 1986

    PubMed  CAS  Google Scholar 

  • Guarner F, Wallace JL, MacNaughton WK, Ibotson GC, Arroyo V, et al. Endotoxin-induced ascites formation in the rat: partial mediation by platelet-activating factor. Hepatology 10: 788–794, 1989

    PubMed  CAS  Google Scholar 

  • Hatano H, Nomura F, Ohnishi K, Iijima T, Hayasaka A, et al. Respective roles of hypoxia and halothane metabolism in halothane-induced liver injury in rats. Hepatology 5: 241–244, 1985

    PubMed  CAS  Google Scholar 

  • Hodges JR, Millward-Sadler GH, Barbatis C, Wright R. Heterozygous MZ α1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis. New England Journal of Medicine 304: 557–560, 1981

    PubMed  CAS  Google Scholar 

  • Hopf U, Riecken E-O, Zeitz M, Eckhardt R, Lobeck H, et al. Immunologische Parameter bei Pericholangitis und primär sklerosierender Cholangitis mit und ohne Colitis ulcerosa. Deutsche Medizinische Wochenschrift 108: 1515–1521, 1983

    PubMed  CAS  Google Scholar 

  • Hörtnagel H, Singer EA, Lenk K. Substance P is markedly increased in plasma of patients with hepatic coma. Lancet 1: 480–483, 1984

    Google Scholar 

  • Huber M, Kästner S, Schölmerich J, Gerok W, Keppler D. Analysis of cysteinyl leukotrienes in human urine: enhanced excretion in patients with liver cirrhosis and hepatorenal syndrome. European Journal of Clinical Investigation 19: 53–60, 1989

    PubMed  CAS  Google Scholar 

  • Hultcrantz R, Angelin B, Björn-Rasmussen E, Ewerth S, Einarsson K. Biliary excretion of iron and ferritin in idiopathic hemochromatosis. Gastroenterology 96: 1539–1545, 1989

    PubMed  CAS  Google Scholar 

  • Hütteroth TH, Poralla T, Meyer zum Büschenfelde K-H. Immunmechanismen bei entzündlichen Lebererkrankungen. Internist 26: 607–613, 1985

    PubMed  Google Scholar 

  • Ishak KG. Hepatic lesions caused by anabolic and contraceptive steroids. Seminars in Liver Diseases 1: 116–128, 1981

    CAS  Google Scholar 

  • Iyengar V, Brewer GJ, Dick RD, Owyang C. Studies of cholecystokinin-stimulated biliary secretions reveal a high molecular weight copper-binding substance in normal subjects that is absent in patients with Wilson’s disease. Journal of Laboratory and Clinical Medicine 111: 267–274, 1988

    PubMed  CAS  Google Scholar 

  • James JH, Ziparo V, Jeppsson B, Fischer JE. Hyperammonaemia, plasma amino acid imbalance and blood-brain amino acid transport: a unified theory of portal-systemic encephalopathy. Lancet 2: 772–775, 1979

    PubMed  CAS  Google Scholar 

  • Kaplan MM. Primary biliary cirrhosis. New England Journal of Medicine 316: 521–528, 1987

    PubMed  CAS  Google Scholar 

  • Kaufman SS, Wood RP, Shaw BW, Markin RS, Rosenthal P, et al. Orthotopic liver transplantation for type I Crigler-Najjar syndrome. Hepatology 6: 1259–1262, 1986

    PubMed  CAS  Google Scholar 

  • Keppler D, Huber RM, Kästner S, Schölmerich J, Gerok W. Leukotrienes and other eicosanoids in the pathophysiology of renal dysfunction in liver disease. Zeitschrift für Gastroenterologie 27: 294–295, 1989

    Google Scholar 

  • Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TX, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 245: 1073–1080, 1989

    PubMed  CAS  Google Scholar 

  • Kleber G, Sauerbruch T. Risk indicators of variceal bleeding. Zeitschrift für Gastroenterologie 26(Suppl. 2): 19–23, 1988

    PubMed  Google Scholar 

  • Klein R, Berg PA. Organ specific antibodies against liver mitochondria (anti-M9) in patients with primary biliary cirrhosis (PBC) and their relatives. Hepatology 4: 750, 1984

    Google Scholar 

  • Krowka M J, Cortese DA. Hepatopulmonary syndrome: an evolving perspective in the era of liver transplantation. Hepatology 11: 138–142, 1990

    PubMed  CAS  Google Scholar 

  • Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redekar AG, et al. An assay for circulating antibodies to a major etiology virus of human non-A, non-B hepatitis. Science 224: 362–364, 1989

    Google Scholar 

  • Lewis JH, Ranard RC, Caruso AN, Jackson LK, Mullick F, et al. Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients. Hepatology 9: 679–685, 1989

    PubMed  CAS  Google Scholar 

  • Liau MC, Chang CF, Belanger L, Grenier A. Correlation of isozyme patterns of S-adenosylmethionine synthetase with fetal stages and pathological states of the liver. Cancer Research 39: 162–169, 1979

    PubMed  CAS  Google Scholar 

  • Lieber CS. Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. New England Journal of Medicine 319: 1639–1650, 1988

    PubMed  CAS  Google Scholar 

  • Lindor KD, Wiesner RH, LaRusso NF, Homburger HA. Enhanced autoreactivity of T-lymphocytes in primary sclerosing Cholangitis. Hepatology 7: 884–888, 1987a

    PubMed  CAS  Google Scholar 

  • Lindor KD, Wiesner RH, LaRusso NF. Recent advances in the management of primary sclerosing cholangitis. Seminars in Liver Diseases 7: 322–327, 1987b

    CAS  Google Scholar 

  • Ludwig J, Axelsen R. Drug effects on the liver. An updated tabular compilation of drugs and drug-related hepatic disease. Digestive Diseases and Sciences 28: 651–666, 1983

    PubMed  CAS  Google Scholar 

  • Manns M. Autoantibodies and antigens in liver diseases — updated. Journal of Hepatology 9: 272–280, 1989

    PubMed  CAS  Google Scholar 

  • Manns M, Johnson EF, Griffin KJ, Tan EM, Sullivan KF. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis in cytochrome P450dbl. Journal of Clinical Investigation 83: 1066–1072, 1989

    PubMed  CAS  Google Scholar 

  • Matern S. Leber. In Siegenthaler W (Ed.) Klinische Pathophysiologie, pp. 864–900, Georg Thieme-Verlag, Stuttgart, 1987

    Google Scholar 

  • McFarlane JG, Woicicka BM, Tsantoolas DC, Portmann BG, Eddleston ALWF, et al. Leukocyte migration inhibition in response to biliary antigens in primary biliary cirrhosis, sclerosing cholangitis, and other chronic liver disease. Gastroenterology 76: 1333–1340, 1979

    PubMed  CAS  Google Scholar 

  • Mieli-Vergani G, Lobo-Yeo A, McFarlane BM, McFarlane IG, Mowat AP, et al. Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood. Hepatology 9: 198–203, 1989

    PubMed  CAS  Google Scholar 

  • Minuk GY, Angus M, Brickman CM, Lawley TJ, Frank MM, et al. Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis. Gastroenterology 88: 166–170, 1988

    Google Scholar 

  • Minuk GY, MacCannell KL. Is the hypotension of cirrhosis a GABA-mediated process? Hepatology 8: 73–77, 1988

    PubMed  CAS  Google Scholar 

  • Muno D, Kominami E, Ishii H, Usui K, Saifuku K, et al. Isolation of tryptic fragment of antigen from mitochondrial inner membrane proteins reacting with antimitochondrial antibody in sera of patients with primary biliary cirrhosis. Hepatology 11: 16–23, 1990

    PubMed  CAS  Google Scholar 

  • Nartey NO, Frei JV, Cherian MG. Hepatic copper and metallothionein distribution in Wilson’s disease (hepatolenticular degeneration). Laboratory Investigation 57: 397–401, 1987

    PubMed  CAS  Google Scholar 

  • Neuberger J, Williams R. Halothane hepatitis. Digestive Diseases 6: 52–64, 1988

    PubMed  CAS  Google Scholar 

  • Nichols GM, Bacon BR. Hereditary hemochromatosis: pathogenesis and clinical features of a common disease. American Journal of Gastroenterology 84: 851–862, 1989

    PubMed  CAS  Google Scholar 

  • Nordmann R, Ribière C, Rouach H. Involvement of iron and iron-catalyzed free radical production in ethanol metabolism and toxicity. Enzyme 37: 57–69, 1987

    PubMed  CAS  Google Scholar 

  • Olomu AB, Vickers CR, Waring RH, Clements D, Babbs C, et al. High incidence of poor sulfoxidation in patients with primary biliary cirrhosis. New England Journal of Medicine 318: 1089–1092, 1988

    PubMed  CAS  Google Scholar 

  • Orrego H, Blendis IM, Crossly IRE. Correlation of intrahepatic pressure with collagen in the Disse space in humans and in the rat. Gastroenterology 80: 546–556, 1981

    PubMed  CAS  Google Scholar 

  • Perez-Ayuso RM, Arroyo V, Camps J, Rimola A, Costa J, et al. Renal kallikrein excretion in cirrhotics with ascites. Relationship to renal hemodynamics. Hepatology 4: 247–252, 1984

    PubMed  CAS  Google Scholar 

  • Pinos T, Constansa JM, Palacin A, Figueras C. A new diagnostic approach to the Dubin-Johnson syndrome. American Journal of Gastroenterology 85: 91–93, 1990

    PubMed  CAS  Google Scholar 

  • Popper H, Keppler D. Networks of interacting mechanisms of hepatocellular degeneration and death. In Popper H, Schaffner F (Eds) Progress in liver diseases, Vol. 8, pp. 209–235 Grune & Stratton, Orlando, 1986

    Google Scholar 

  • Popper H, Lieber CS. Die alkoholische Zirrhose folgt nicht notwendigerweise der Alkoholhepatitis. Internist 20: 176–178, 1979

    PubMed  CAS  Google Scholar 

  • Powell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11: 74–80, 1990

    PubMed  Google Scholar 

  • Quigley EMM, LaRusso NF, Ludwig J, MacSween RNM, Birnie GG, et al. Familial occurrence of primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 85: 1160–1165, 1983

    PubMed  CAS  Google Scholar 

  • Rakela J, Goldschmiedt M, Ludwig J. Late manifestation of chronic liver disease in adults with α1-antitrypsin deficiency. Digestive Diseases and Sciences 32: 1358–1362, 1987

    PubMed  CAS  Google Scholar 

  • Reichen J. Etiology and pathophysiology of portal hypertension. Zeitschrift für Gastroenterologie 26(Suppl. 2): 3–7, 1988

    PubMed  Google Scholar 

  • Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066–1073, 1989

    PubMed  CAS  Google Scholar 

  • Rizzetto M, Hoyer B, Canese MG, Shih JWK, Purcell RH, et al. Delta antigen: the association of delta antigen with hepatitis B surface antigen and ribonucleic acid in the serum of delta infected chimpanzees. Proceedings of the National Academy of Sciences of the United States of America 77: 6124–6128, 1980

    PubMed  CAS  Google Scholar 

  • Rizzetto M, Verme G. Die Delta-Hepatitis. Internist 26: 628–632, 1985

    PubMed  CAS  Google Scholar 

  • Roggendorf M. Hepatitis C Virus. Deutsche Medizinische Wochenschrift 115: 352–354, 1990

    PubMed  CAS  Google Scholar 

  • Roijkind M, Giambrone MA, Biempica L. Collagen types in normal and fibrotic liver. Gastroenterology 76: 710–719, 1979

    Google Scholar 

  • Rommens JM, Iannuzzi MC, Kerem B-S, Drumm ML, Melmer G, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245: 1059–1065, 1989

    PubMed  CAS  Google Scholar 

  • Rosen HM, Yoshimura N, Hodgman JM, Fischer JE. Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology 72: 483–487, 1977

    PubMed  CAS  Google Scholar 

  • Rubin E. Iatrogenic hepatic injury. Human Pathology 11: 312–331, 1980

    PubMed  CAS  Google Scholar 

  • Runyon BA. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology 8: 632–635, 1988

    PubMed  CAS  Google Scholar 

  • Said SI. Candidate hormones of the gut. V. Vasoactive intestinal peptide (VIP). Gastroenterology 67: 735–737, 1974

    PubMed  CAS  Google Scholar 

  • Sakagami Y, Mizoguchi Y, Seki S, Kobayashi K, Morisawa S, et al. Release of peptide leukotrienes from rat Kupffer cells. Biochemical and Biophysical Research Communications 156: 217–221, 1988

    PubMed  CAS  Google Scholar 

  • Saunders JB, Wodak AD, Haines A, Powell-Jackson PR, Portmann B, et al. Accelerated development of alcoholic cirrhosis in patients with HLA-B8. Lancet 1: 1381–1384, 1982

    PubMed  CAS  Google Scholar 

  • Schafer DR, Jones EA. Hepatic encephalopathy and the γ-aminobutyric-acid neurotransmitter system. Lancet 1: 18–19, 1982

    PubMed  CAS  Google Scholar 

  • Schaffner F, Bach N. Gastrointestinal syndromes in primary biliary cirrhosis. Seminars in Liver Disease 8: 263–271, 1988

    PubMed  CAS  Google Scholar 

  • Scheinberg IH, Sternlieb I. Wilson’s disease. Major problems in internal medicine, Vol. 23, WB Saunders & Company, Philadelphia, 1984

    Google Scholar 

  • Schneider M, Pott G, Gerlach U. α1-Antitrypsin-Mangel. Klinische Wochenschrift 64: 197–205, 1986

    PubMed  CAS  Google Scholar 

  • Schoenfield LJ, McGill DB, Hunton DB, Foulk WT, Butt HR. Studies of chronic idiopathic jaundice (Dubin-Johnson syndrome). I. Demonstration of hepatic excretory defect. Gastroenterology 44: 101–111, 1963

    PubMed  CAS  Google Scholar 

  • Schölmerich J, Bennett M, Johnson AC, Miyai K, DeLuca M, et al. Utility of serum bile acid levels as measured by bioluminescence for detection of methotrexate induced liver injury in patients with psoriasis. Clinical Chemistry and Enzymology Communications 2: 143–150, 1990

    Google Scholar 

  • Schrier RW. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis and pregnancy (first of two parts). New England Journal of Medicine 319: 1065–1072, 1988

    PubMed  CAS  Google Scholar 

  • Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, et al. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8: 1151–1157, 1988

    PubMed  CAS  Google Scholar 

  • Schrumpf E, Fausa O, Førre Ø, Dobloug JH, Ritland S, et al. HLA-antigens and immunoregulatory T-cells in ulcerative colitis associated with hepatobiliary disease. Scandinavian Journal of Gastroenterology 17: 187–191, 1982

    PubMed  CAS  Google Scholar 

  • Schuppan D, Hahn EG, Rieken EO. Änderungen des Bindegewebsstoffwechsels bei alkoholbedingter Leberfibrose. Zeitschrift für Gastroenterologie 26(Suppl. 3): 28–38, 1988

    PubMed  Google Scholar 

  • Seeff LB. Drug-induced chronic liver disease, with emphasis on chronic active hepatitis. Seminars in Liver Diseases 1: 104–115, 1981

    CAS  Google Scholar 

  • Sheen I-S, Liaw Y-F, Tai D-I, Chu C-M. Hepatic decompensation associated with hepatitis B e antigen clearance in chronic type B hepatitis. Gastroenterology 89: 732–735, 1985

    PubMed  CAS  Google Scholar 

  • Sherlock S. The clinician looks at fatty liver. In Shaffer E, Thomson ABR (Eds) Modern concepts in gastroenterology, Vol. 2, pp. 1–24, Plenum Medical Book Company, New York, 1988

    Google Scholar 

  • Shiratori Y, Kawase T, Shina S, Okano K, Sugimoto T, et al. Modulation of hepatotoxicity by macrophages in the liver. Hepatology 8: 815–821, 1988

    PubMed  CAS  Google Scholar 

  • Si L, Whiteside TL, Schade RR, Starzl TE, van Thiel DH. T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls. Journal of Clinical Immunology 4: 262–272, 1984

    PubMed  CAS  Google Scholar 

  • Simon M, Brissot P. The genetics of haemochromatosis. Journal of Hepatology 6: 116–124, 1988

    PubMed  CAS  Google Scholar 

  • Smedile A, Farci P, Verme G, Caredda F, Cargnel A, et al. Influence of delta infection on severity of hepatitis B. Lancet 2: 945–947, 1982

    PubMed  CAS  Google Scholar 

  • Snook JA, Chapman RW, Fleming K, Jewell DP. Anti-neutrophil nuclear antibody in ulcerative colitis. Crohn’s disease and primary sclerosing cholangitis. Clinical and Experimental Immunology 76: 30–33, 1989

    PubMed  CAS  Google Scholar 

  • Spech HJ, Liehr H, Mitschke H. Nicht alkoholbedingte Fettle-berhepatitiden und Fettzirrhosen unter dem täuschenden Bild alkoholtoxischer Lebererkrankungen. Zeitschrift für Gastroenterologie 21: 651–659, 1983

    PubMed  CAS  Google Scholar 

  • Stemerowicz R, Hopf U, Möller B, Wittenbrink C, Rodloff A, et al. Are antimitochondrial antibodies in primary biliary cirrhosis induced by R (rough)-mutants of enterobacteriaceae? Lancet 2: 1166–1170, 1988

    PubMed  CAS  Google Scholar 

  • Sternlieb I. Copper and the liver. Gastroenterology 78: 1615–1628, 1980

    PubMed  CAS  Google Scholar 

  • Summerfield JA, Kirk AP, Chitranukroh A, Billing BH. A distinctive pattern of serum bile acid and bilirubin concentrations in benign recurrent intrahepatic cholestasis. Hepato-Gastro-enterology 28: 139–142, 1981

    CAS  Google Scholar 

  • Surh CD, Danner DJ, Ahmed A, Coppel RL, Mackay IR, et al. Reactivity of primary biliary cirrhosis sera with a human fetal liver cDNA clone of branched-chain α-keto acid dehydrogenase dihydrolipoamide acyltransferase, the 52 kD mitochondrial autoantigen. Hepatology 9: 63–68, 1989

    PubMed  CAS  Google Scholar 

  • Tait B, Mackay IR, Board P, Coggan M, Emery P, et al. HLA Al, B8, DR3 extended haplotypes in autoimmune chronic hepatitis. Gastroenterology 97: 479–481, 1989

    PubMed  CAS  Google Scholar 

  • Takahashi F, Das KM. Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis. Journal of Clinical Investigation 76: 311–318, 1985

    PubMed  CAS  Google Scholar 

  • Teschke R. Arzneimittel und Leberschäden. Therapiewoche 36: 2959–2966, 1986

    Google Scholar 

  • Thornton JR, Dean H, Losowsky MS. Is ascites caused by impaired hepatic inactivation of blood borne endogenous opioid peptides? Gut 29: 1167–1172, 1988

    PubMed  CAS  Google Scholar 

  • Tiribelli C, Ostrow JD. New concepts in bilirubin chemistry, transport and metabolism: report of the international bilirubin workshop. Hepatology 11: 303–313, 1990

    PubMed  CAS  Google Scholar 

  • Touloukian J, Kaplowitz N. Halothane-induced hepatic disease. Seminars in Liver Disease 1: 134–142, 1981

    PubMed  CAS  Google Scholar 

  • Trewby PN, Williams R. Pathophysiology of hypotension in patients with fulminant hepatic failure. Gut 18: 1021–1026, 1977

    PubMed  CAS  Google Scholar 

  • Triger DR, Boyer TD, Levin J. Portal and systemic bacteriaemia and endotoxaemia in liver disease. Gut 19: 935–939, 1978

    PubMed  CAS  Google Scholar 

  • Valla D, Benhamou J-P. Liver diseases related to oral contraceptives. Digestive Diseases 6: 76–86, 1988

    PubMed  CAS  Google Scholar 

  • Valla D, Flejou J-F, Lebrec D, Bernuau J, Rueff B, et al. Portal hypertension and ascites in acute hepatitis: clinical, hemodynamic and histological correlations. Hepatology 10: 482–487, 1989

    PubMed  CAS  Google Scholar 

  • Van de Water J, Fregeau D, Davis P, Ansari A, Danner P, et al. Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function. Journal of Immunology 141: 2321–2324, 1988

    Google Scholar 

  • Vergani D, Mieli-Vergani G, Alberti A, Neuberger J, Eddleston ALWF, et al. Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. New England Journal of Medicine 303: 66–71, 1980

    PubMed  CAS  Google Scholar 

  • Vidins EI, Britton RS, Medline A, Blendis LM, Israel Y, et al. Sinusoidal caliber in alcoholic and nonalcoholic liver disease: diagnostic and pathogenic implications. Hepatology 5: 408–414, 1985

    PubMed  CAS  Google Scholar 

  • Vierling JM, Berk PD, Hofmann AF, Martin JF, Wolkoff AW, et al. Normal fasting-state levels of serum cholyl-conjugated bile acids in Gilbert’s syndrome: an aid to the diagnosis. Hepatology 2: 340–343, 1982

    PubMed  CAS  Google Scholar 

  • Villa E, Rubbiani L, Barchi T, Ferretti I, Grisendi A, et al. Susceptibility of chronic symptomless HBsAg carriers to ethanol-induced hepatic damage. Lancet 2: 1243–1244, 1982

    PubMed  CAS  Google Scholar 

  • Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. American Journal of Physiology 244: G52–G57, 1983

    PubMed  CAS  Google Scholar 

  • Weiss KC, Linder MC. Copper transport in rats involving a new plasma protein. American Journal of Physiology 249: E77–E88, 1985

    PubMed  CAS  Google Scholar 

  • Whittaker P, Skikne BS, Covell AM, Flowers C, Cooke A, et al. Duodenal iron proteins in idiopathic hemochromatosis. Journal of Clinical Investigation 83: 261–267, 1989

    PubMed  CAS  Google Scholar 

  • Witte CL, Witte MH, Dumont AE. Lymph imbalance in the genesis and perpetuation of ascites syndrome in hepatic cirrhosis. Gastroenterology 78: 1059–1066, 1980

    PubMed  CAS  Google Scholar 

  • Wolkoff AW, Cohen LE, Arias IM. Inheritance of the Dubin-Johnson syndrome. New England Journal of Medicine 288: 113–117, 1973

    PubMed  CAS  Google Scholar 

  • Wolkoff AW, Wolpert E, Pascasio FN, Arias IM. Rotor’s syndrome. A distinct inheritable pathophysiologic entity. American Journal of Medicine 60: 173–179, 1976

    PubMed  CAS  Google Scholar 

  • Wong PY, Talamo RC, Williams GH. Kallikrein-kinin and reninangiotension systems in functional renal failure of cirrhosis of the liver. Gastroenterology 73: 1114–1118, 1977

    PubMed  CAS  Google Scholar 

  • Yazaki Y. Hepatic copper concentrations in various liver diseases. Acta Hepatologica Japonica 25: 1260–1272, 1984

    Google Scholar 

  • Zanger UM, Hauri H-P, Loeper J, Homberg J-C, Meyer UA. Antibodies against human cytochrome P-450dbl in autoimmune hepatitis type II. Proceedings of the National Academy of Sciences of the United States of America 85: 8256–8260, 1988

    PubMed  CAS  Google Scholar 

  • Zieve L, Doizaki WM. Brain and blood methanethiol and ammonia concentrations in experimental hepatic coma and coma due to injections of various combinations of these substances. Gastroenterology 79: 1070, 1980

    Google Scholar 

  • Zimmermann HJ. Drug-induced liver disease: an overview. Seminars in Liver Disease 1: 93–103, 1981

    Google Scholar 

  • Zipser RD, Kerlin P, Hoefs JC, Zia P, Barg A. Renal kallikrein excretion in alcoholic cirrhosis. American Journal of Gastroenterology 75: 183–187, 1981

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University of Freiburg, Hugstetterstrasse 55, D-7800, Freiburg, Germany

    J. Schölmerich & A. Holstege

Authors
  1. J. Schölmerich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Holstege
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schölmerich, J., Holstege, A. Aetiology and Pathophysiology of Chronic Liver Disorders. Drugs 40 (Suppl 3), 3–22 (1990). https://doi.org/10.2165/00003495-199000403-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199000403-00003

Keywords

Search

Navigation